MARONESE, CARLO ALBERTO
 Distribuzione geografica
Continente #
AS - Asia 4.047
NA - Nord America 2.856
EU - Europa 2.748
SA - Sud America 417
AF - Africa 81
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.182
Nazione #
US - Stati Uniti d'America 2.693
CN - Cina 1.308
SG - Singapore 1.119
IT - Italia 850
DE - Germania 508
HK - Hong Kong 355
BD - Bangladesh 300
BR - Brasile 289
VN - Vietnam 253
RU - Federazione Russa 236
IN - India 203
ES - Italia 200
FR - Francia 190
GB - Regno Unito 159
SE - Svezia 144
JP - Giappone 124
NL - Olanda 106
CA - Canada 95
TR - Turchia 89
ID - Indonesia 73
FI - Finlandia 70
KR - Corea 66
PL - Polonia 61
AR - Argentina 47
IE - Irlanda 45
MX - Messico 41
CI - Costa d'Avorio 32
AU - Australia 29
CO - Colombia 28
SA - Arabia Saudita 27
TW - Taiwan 27
AT - Austria 26
RO - Romania 21
BE - Belgio 20
PT - Portogallo 20
IQ - Iraq 19
IL - Israele 18
VE - Venezuela 17
CZ - Repubblica Ceca 16
GR - Grecia 15
ZA - Sudafrica 13
CL - Cile 12
DK - Danimarca 10
UA - Ucraina 10
PE - Perù 9
AE - Emirati Arabi Uniti 8
KE - Kenya 8
PH - Filippine 7
PK - Pakistan 7
TN - Tunisia 7
UZ - Uzbekistan 7
TH - Thailandia 6
BY - Bielorussia 5
DZ - Algeria 5
EC - Ecuador 5
JM - Giamaica 5
LT - Lituania 5
LU - Lussemburgo 5
AL - Albania 4
HR - Croazia 4
HU - Ungheria 4
JO - Giordania 4
UY - Uruguay 4
AZ - Azerbaigian 3
CR - Costa Rica 3
ET - Etiopia 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LB - Libano 3
MA - Marocco 3
NI - Nicaragua 3
PS - Palestinian Territory 3
PY - Paraguay 3
BG - Bulgaria 2
BO - Bolivia 2
CD - Congo 2
CH - Svizzera 2
EE - Estonia 2
EG - Egitto 2
HN - Honduras 2
IR - Iran 2
MD - Moldavia 2
MT - Malta 2
MY - Malesia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PA - Panama 2
PR - Porto Rico 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
AO - Angola 1
BH - Bahrain 1
BW - Botswana 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GT - Guatemala 1
HT - Haiti 1
Totale 10.167
Città #
Singapore 539
Ashburn 489
Frankfurt am Main 317
Hong Kong 300
Hefei 252
Dallas 236
San Jose 219
Milan 205
Beijing 181
Los Angeles 159
New York 128
Council Bluffs 124
Chandler 120
Santa Clara 102
Bengaluru 90
Ho Chi Minh City 79
Lauterbourg 77
Rome 67
Shanghai 61
Munich 60
Hanoi 59
Madrid 58
Boardman 54
Jakarta 54
Buffalo 50
São Paulo 50
Tokyo 48
Dublin 44
Guangzhou 44
Helsinki 43
Moscow 40
Seoul 38
Abidjan 32
Southend 32
Florence 30
Atlanta 27
Barcelona 27
Warsaw 27
Bologna 26
Nuremberg 26
Phoenix 26
Chennai 24
London 24
Montreal 21
Naples 21
Toronto 21
Istanbul 20
Cangzhou 19
Memphis 19
Rio de Janeiro 19
Shenzhen 19
Turin 19
Ankara 18
Düsseldorf 18
Princeton 18
Stockholm 18
Riyadh 17
Washington 17
Lappeenranta 16
Paris 16
Brooklyn 15
Denver 15
Houston 15
Trieste 15
Orem 14
Sydney 14
Bogotá 13
Catania 13
Tianjin 13
Valencia 13
Wuhan 13
Berlin 12
Brussels 12
Buenos Aires 12
Chengdu 12
Chicago 12
Da Nang 12
Izmir 12
Fuzhou 11
Haiphong 11
Hangzhou 11
Johannesburg 11
Palermo 11
Rho 11
Tel Aviv 11
Turku 11
Amsterdam 10
Boston 10
Hamburg 10
Las Vegas 10
Lisbon 10
Mexico City 10
Parma 10
Pune 10
San Francisco 10
Taipei 10
Takasaki 10
Belo Horizonte 9
Brno 9
Gainesville 9
Totale 5.466
Nome #
Clinicopathological definition, management and prognostic value of mogamulizumab‐associated rash and other cutaneous events: A systematic review 695
Phenotypic switch from atopic dermatitis to psoriasis during treatment with upadacitinib 608
Dermoscopic predictors of melanoma in small diameter melanocytic lesions (mini-melanoma): a retrospective multicentric study of 269 cases 379
Effectiveness of Dupilumab and Omalizumab in Bullous Pemphigoid: A Nationwide Retrospective Cohort Study 265
Refractory disseminated superficial actinic porokeratosis effectively treated with cholesterol/lovastatin cream: a case report 261
Dermoscopy of dermal duct tumour 234
The Bowel-Associated Arthritis-Dermatosis Syndrome (BADAS): A Systematic Review 217
Neutrophilic and eosinophilic dermatoses associated with hematological malignancy 200
Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments 195
Lymphomatoid papulosis associated with myeloid neoplasm with eosinophilia and FIP1L1::PDGFRA rearrangement: Successful imatinib treatment in two cases 192
Keratosis lichenoides chronica: A case report and focused overview of the literature 186
Clinical and serological predictors of relapse in pemphigus: a study of 143 patients 185
IgG and IgE Autoantibodies to IgE Receptors in Chronic Spontaneous Urticaria and Their Role in the Response to Omalizumab 182
Elevation of peripheral blood eosinophils during dupilumab treatment for atopic dermatitis is associated with baseline comorbidities and development of facial redness dermatitis and ocular surface disease 171
Skin barrier status during dupilumab treatment in patients with severe atopic dermatitis 157
Persistent variant of acquired verrucous perforating collagenoma 154
Real-world data on primary cutaneous lymphoproliferative disorders following SARS-CoV-2 vaccination: A multicentre experience from tertiary referral hospitals 151
Clinical, dermoscopic and histopathological findings in localized human monkeypox: a case from northern Italy 151
Cutaneous vasculitis and vasculopathy in the era of COVID-19 pandemic 148
Interleukin-17 vs. Interleukin-23 Inhibitors in Pustular and Erythrodermic Psoriasis: A Retrospective, Multicentre Cohort Study 147
Ulcerative injection site reaction after third COVID-19 vaccine dose with mRNA-1273 147
Clinical, genetic, and ultrasonographic features of periumbilical perforating pseudoxanthoma elasticum 144
Primary cutaneous gamma-delta T cell lymphomas: a case series and overview of the literature 140
Monkeypox: An Italian, multicentre study of 104 cases 136
SARS-CoV-2 Detection by Digital Polymerase Chain Reaction and Immunohistochemistry in Skin Biopsies from 52 Patients with Different COVID-19-Associated Cutaneous Phenotypes 133
Pustular psoriasis : from pathophysiology to treatment 133
Reply to "Switch from ustekinumab to guselkumab in patients with psoriasis in real clinical practice using the "minimal disease activity" parameter" 131
Bullous pemphigoid associated with COVID-19 vaccines : An Italian multicentre study 130
Unilesional monkeypox: A report of two cases from Italy 123
Maculopapular rash: An overlooked monkeypox diagnostic clue? 123
Faint pigment network in atypical vascular proliferation of the breast: A potential dermoscopic pitfall 123
Three cases of symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by proton-pump inhibitors 120
Yellowish papules on the palms: a diagnostic challenge 119
Dermal Amyloid Deposits: A Possible Misleading Pathologic Finding 118
Yao syndrome: a novel systemic autoinflammatory disease with cutaneous manifestations 117
Brunsting-Perry pemphigoid: a systematic review 116
Autoinflammation in Syndromic Hidradenitis Suppurativa: The Role of AIM2 115
Urticarial vasculitis: Clinical and laboratory findings with a particular emphasis on differential diagnosis 115
Dermoscopy Use Leads to Earlier Cutaneous Melanoma Diagnosis in Terms of Invasiveness and Size? A Single-Center, Retrospective Experience 113
Extranodal disseminated Rosai-Forfman-destombes disease with cutaneous, articular and cardiac involvement 113
The clinical and pathologic spectrum of mucocutaneous reactions after COVID-19 vaccinations in three tertiary referral centers of northern Italy 112
The Intriguing Links between Psoriasis and Bullous Pemphigoid 111
Indeterminate cell histiocytosis in paediatric population: a review of the literature 110
Paradoxical Psoriasis: An Updated Review of Clinical Features, Pathogenesis, and Treatment Options 107
Syphilis and monkeypox co-infection: Coincidence, synergy or asymptomatic carriage? 106
COVID 19-associated chilblain-like acral lesions among children and adolescents: an Italian retrospective, multicenter study 105
Cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: a real-life multicentre experience 103
Anti-IL-17/23 Drugs for the Treatment of Moderate-to-Severe Hidradenitis Suppurativa in Patients With Concomitant Psoriasis: A Multicenter Retrospective Study 102
Generalized eruptive histiocytosis mimicking disseminated molluscum contagiosum: a case report 101
Eruptive pyogenic granulomas following coronavirus disease 2019 101
Skin manifestations associated with checkpoint inhibitors 99
Genetic screening in new onset inflammatory bowel disease during anti-interleukin 17 therapy: unmet needs and call for action 97
Different molecular pathways are disrupted in Pyoderma gangrenosum patients and are associated with the severity of the disease 89
Reply to “New-onset bullous pemphigoid after inactivated Covid-19 vaccine: Synergistic effect of the Covid-19 vaccine and vildagliptin” 87
A unique case of steroid-resistant, giant cellulitis-like Sweet syndrome mimicking alpha-1-antitrypsin deficiency-associated panniculitis: successful treatment with dapsone 85
Pyoderma gangrenosum: pathogenetic mechanisms and their implications for treatment 84
Interleukin-13 in immunohistochemistry: implications for Grover disease, morphea, and immune checkpoint inhibitor-induced bullous pemphigoid 83
Association between maternal dupilumab exposure and pregnancy outcomes in patients with moderate-to-severe atopic dermatitis: A nationwide retrospective cohort study 82
Editorial: Cutaneous immunology 76
Identifying Candidates for Immunotherapy among Patients with Non-Melanoma Skin Cancer: A Review of the Potential Predictors of Response 74
Dermoscopy of apocrine adenocarcinoma of the axilla 72
IRAK4: A novel target in the therapeutic landscape of hidradenitis suppurativa? 71
Recommendations for the diagnostic work-up of cutaneous small vessel vasculitis - Position Statement of the European Academy of Dermatology and Venereology Vasculitis and Vasculopathy Task Force 67
Granuloma annulare-like pseudohistiocytosis: a specific manifestation of ETV6::SYK-rearranged myeloid neoplasm with eosinophilia 62
Acute generalized exanthematous pustulosis: 15-year retrospective multicenter experience 62
Hidradenitis Suppurativa-Related Autoinflammatory Syndromes: An Updated Review on the Clinics, Genetics, and Treatment of Pyoderma gangrenosum, Acne and Suppurative Hidradenitis (PASH), Pyogenic Arthritis, Pyoderma gangrenosum, Acne and Suppurative Hidradenitis (PAPASH), Synovitis, Acne, Pustulosis, Hyperostosis and Osteitis (SAPHO), and Rarer Forms 61
Successful treatment of Hailey-Hailey disease with oral roflumilast 58
Vitiligo: Unmet Need, Management and Treatment Guidelines 57
HIDRADENITIS SUPPURATIVA WITH 20 OR MORE DRAINING TUNNELS: A NATION-WIDE RETROSPECTIVE STUDY. 55
Dermoscopy and ultrasonography of Kaposi’s sarcoma nodules: new insights to guide intralesional chemotherapy? 53
Anal pruritus caused by Dientamoeba fragilis 50
Identifying candidates for early intervention in hidradenitis suppurativa 49
Effectiveness of nanofat in treatment-refractory penile lichen sclerosus: results from a pilot retrospective single-center case series 47
Urticarial vasculitis following mRNA anti-COVID-19 vaccine 47
Successful Treatment of PAPASH Syndrome With Concomitant FMF Using IL-1 Blockade: A Case Report 47
Ultrasonographic diagnosis of erythema nodosum 46
Has the time come to assess small-molecule/biologic drug combinations for the management of moderate-to-severe hidradenitis suppurativa? 42
Fatal Toxic Epidermal Necrolysis-Like Lupus Erythematosus in a Patient With Metastatic Histiocytic Sarcoma 39
Effectiveness and safety of Tildrakizumab in elderly and frail elderly psoriatic patients up to 2 years 38
Lupus vorax: A rare case of facial tuberculosis in a patient with Noonan syndrome 34
What is 'chronic' pustular psoriasis? Identifying candidates for long-term subcutaneous spesolimab treatment 33
Romosozumab for glucocorticosteroid-induced osteoporosis in patients with autoimmune blistering diseases: primum non nocere 32
Keratin Variants in Pyoderma Gangrenosum: Pathogenetic Insights from a Whole-Exome SequencingeBased Bioinformatic Analysis 22
Dissecting Cellulitis of the Scalp: Current Insights and Therapeutic Advances 17
null 14
Amicrobial pustulosis of the folds successfully treated with apremilast: report of two cases and review of the literature 10
Idiopathic cutaneous immunoglobulin G/immunoglobulin M vasculitis is likely a distinct entity: A European multicentric retrospective study 10
Short-, mid- and long-term efficacy of dupilumab in moderate-to-severe atopic dermatitis: a real-world multicentre Italian study of 2576 patients 9
Deucravacitinib for the treatment of cutaneous lupus erythematosus: a 9-patient case series 8
Selective IL-23 Inhibition in Conventional Treatment-Refractory Pyoderma Gangrenosum: A Multicenter, Retrospective Study 5
Long-Term Outcomes of Secukinumab in Moderate-to-Severe Hidradenitis Suppurativa: A Multicentre Cohort Study 3
Subcutaneous Spesolimab for Amicrobial Pustulosis of the Folds 1
Totale 10.522
Categoria #
all - tutte 30.795
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.795


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202115 0 0 0 0 0 0 0 0 0 0 0 15
2021/2022246 2 16 6 4 23 28 17 25 22 15 18 70
2022/2023641 45 58 34 48 70 64 27 63 87 29 86 30
2023/20241.133 40 80 50 105 219 78 89 81 42 86 137 126
2024/20252.195 115 209 114 157 160 103 118 183 118 217 237 464
2025/20266.271 586 578 669 636 542 348 592 323 575 380 642 400
Totale 10.522